Edition:
United States

Globus Medical Inc (GMED.N)

GMED.N on New York Stock Exchange

30.97USD
25 May 2017
Change (% chg)

$0.38 (+1.24%)
Prev Close
$30.59
Open
$30.70
Day's High
$31.32
Day's Low
$30.63
Volume
121,365
Avg. Vol
181,947
52-wk High
$33.05
52-wk Low
$19.40

Latest Key Developments (Source: Significant Developments)

Globus Medical says received letter from FDA regarding 510(K) submission for Excelsiusgps
Wednesday, 17 May 2017 04:34pm EDT 

May 17 (Reuters) - Globus Medical Inc :Globus Medical - received letter from FDA informing co had not sufficiently addressed questions regarding 510(K) submission for Excelsiusgps.Globus Medical - co had not sufficiently addressed FDA's questions within FDA review period required for clearance under rules governing 510(K) process.Globus Medical - company intends to file a revised 510(K) submission for Excelsiusgps in an expedited fashion.Globus Medical - in light of FDA correspondence, co no longer anticipates obtaining FDA clearance for Excelsiusgps during second calendar quarter.Globus Medical - company reaffirms guidance for full year 2017 sales of $625 million and non-GAAP fully diluted earnings per share of $1.27.  Full Article

Globus Medical reports Q1 earnings per share of $0.30
Wednesday, 3 May 2017 04:15pm EDT 

May 3 (Reuters) - Globus Medical Inc :Globus Medical reports first quarter 2017 results.Q1 non-GAAP earnings per share $0.32.Q1 earnings per share $0.30.Q1 sales $155.8 million versus i/b/e/s view $149.8 million.Sees fy 2017 non-gaap earnings per share $1.27.Sees fy 2017 sales $625 million.Q1 earnings per share view $0.31 -- Thomson Reuters I/B/E/S.company reaffirms guidance for full year 2017 sales of $625 million and non-gaap fully diluted earnings per share of $1.27.Fy2017 earnings per share view $1.28 -- Thomson Reuters I/B/E/S.Fy2017 revenue view $624.9 million -- Thomson Reuters I/B/E/S.  Full Article

Globus Medical files for non-timely 10-K
Wednesday, 1 Mar 2017 06:29am EST 

Globus Medical Inc : Globus Medical Inc files for non-timely 10-K .Globus Medical - Anticipates filing its form 10-K for the fiscal year ended December 31, 2016 within the extension period.  Full Article

Globus Medical Q4 non-gaap EPS $0.31
Monday, 27 Feb 2017 04:41pm EST 

Globus Medical Inc : Globus medical reports full year and fourth quarter 2016 results . Q4 non-gaap earnings per share $0.31 . Q4 earnings per share $0.25 . Q4 earnings per share view $0.33 -- Thomson Reuters I/B/E/S . Sees fy 2017 non-gaap earnings per share $1.27 . Sees fy 2017 sales $625 million . Q4 sales $151.6 million versus i/b/e/s view $149.3 million .Fy2017 earnings per share view $1.27, revenue view $624.0 million -- Thomson Reuters I/B/E/S.  Full Article

Globus Medical reports Q3 earnings per share $0.27
Tuesday, 8 Nov 2016 04:15pm EST 

Globus Medical Inc: Globus medical reports third quarter 2016 results . Reports Q3 sales down 1 percent . Q3 non-gaap earnings per share $0.29 . Q3 earnings per share $0.27 . Sees FY 2017 sales $625 million . Sees FY 2016 sales $560 million . Company issues new 2016 guidance for sales of $560 million . Q3 revenue $135.7 million versus i/b/e/s view $139.2 million . Q3 earnings per share view $0.29 -- Thomson Reuters I/B/E/S . Sees FY 2016 gaap earnings per share of approximately $1.13 . Sees FY 2016 guidance for non-gaap diluted eps at $1.20 per share. . Company currently projects 2017 full year sales of $625 million . FY 2016 earnings per share view $1.20, revenue view $574.8 million -- Thomson Reuters I/B/E/S .FY 2017 revenue view $640.0 million -- Thomson Reuters I/B/E/S.  Full Article

Globus Medical enters agreement with Alphatec and Alphatec Spine
Friday, 2 Sep 2016 09:21am EDT 

Globus Medical Inc : Says entered into a credit, security and guaranty agreement with Alphatec And Alphatec Spine, Inc. . Says agreement made available to Alphatec borrowers senior secured term loan facility in an amount not to exceed $30 million. .Credit agreement has a scheduled maturity date five years from closing date..  Full Article

Globus Medical to buy Alphatec’s international business for $80 mln in cash
Tuesday, 26 Jul 2016 04:30pm EDT 

Globus Medical Inc : Globus Medical announces the acquisition of Alphatec’s international business .Deal for $80.0 million in cash.  Full Article

Alphatec Holdings announces sale of international business to Globus Medical
Tuesday, 26 Jul 2016 04:30pm EDT 

Alphatec Holdings Inc : Alphatec Holdings announces sale of international business to Globus Medical . As part of transaction, Globus has also agreed to provide Alphatec a five-year senior secured credit facility of up to $30 million . Expects to use portions of cash consideration to pay down approximately $69 million of existing debt and debt-related costs . Globus will acquire Alphatec's international distribution operations and agreements . Alphatec holdings announces sale of international business to Globus Medical .Deal for $80 million.  Full Article

Globus Medical Q2 non-gaap earnings per share $0.29
Tuesday, 26 Jul 2016 04:30pm EDT 

Globus Medical Inc : Preliminarily projects 2017 full year sales of $640M including $40M from acquisition . FY2016 earnings per share view $1.20, revenue view $583.1 million -- Thomson Reuters I/B/E/S . Globus Medical reports second quarter 2016 results . Q2 non-gaap earnings per share $0.29 . Q2 earnings per share $0.27 . Q2 earnings per share view $0.29 -- Thomson Reuters I/B/E/S . Sees FY 2016 sales about $575 million . Q2 revenue $137.5 million versus I/B/E/S view $141.8 million .Sees full year 2016 gaap earnings per share of approximately $1.17.  Full Article

Acacia Research says Bonutti Skeletal Innovations entered into settlement, license agreement with Globus Medical
Friday, 10 Jun 2016 06:13am EDT 

Acacia Research Corp : Bonutti Skeletal Innovations Llc entered into a settlement and license agreement with Globus Medical Inc - sec filing .Agreement resolves patent litigation pending in united states district court for eastern district of pennsylvania.  Full Article

More From Around the Web

BRIEF-Globus Medical says received letter from FDA regarding 510(K) submission for Excelsiusgps

* Globus Medical - received letter from FDA informing co had not sufficiently addressed questions regarding 510(K) submission for Excelsiusgps